A Phase I Study of the Oral Platinum Agent Satraplatin in Combination with Oral Vinorelbine in Patients with Advanced Solid Malignancies

Publisher： Karger

E-ISSN： 2296-5262|36|1-2|40-45

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.36, Iss.1-2, 2013-01, pp. : 40-45

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase I Study of Two Schedules of Oral S-1 in Combination with Fixed Doses of Oxaliplatin and Bevacizumab in Patients with Advanced Solid Tumors

By  

Oncology, Vol. 81, Iss. 2, 2011-09 ,pp. : 65-72

Karger

Access to resources Recommend Favorite

A phase I clinical and pharmacokinetic study of tipifarnib in combination with docetaxel in patients with advanced solid malignancies

By Awada Ahmad   Zhang Steven   Gil Thierry   de Valeriola Dominique   Lalami Yassine   De Porre Peter   Piccart-Gebhart Martine J.  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 991-1003

Informa Healthcare

Access to resources Recommend Favorite

Phase 1 trial and pharmacokinetic study of the oral platinum analog satraplatin in children and young adults with refractory solid tumors including brain tumors

By  

PEDIATRIC BLOOD & CANCER (ELECTRONIC), Vol. 62, Iss. 4, 2015-04 ,pp. : 603-610

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase I Dose-Escalation and Pharmacokinetic Study of Intravenous Aflibercept in Combination with Docetaxel, Cisplatin, and 5-Fluorouracil in Patients with Advanced Solid Malignancies

By  

Oncology, Vol. 90, Iss. 1, 2016-0 ,pp. : 10-20

Karger

Access to resources Recommend Favorite

Phase III Trial of Satraplatin, an Oral Platinum plus Prednisone vs. Prednisone alone in Patients with Hormone-Refractory Prostate Cancer

By  

Oncology, Vol. 68, Iss. 1, 2005-04 ,pp. : 2-9

Karger

Access to resources Recommend Favorite